Global Boron Neutron Capture Therapy (BNCT) for Cancer Treatment Market Growth (Status and Outlook) 2024-2030

Global Boron Neutron Capture Therapy (BNCT) for Cancer Treatment Market Growth (Status and Outlook) 2024-2030

Boron Neutron Capture Therapy (BNCT) is a radiation science which is emerging as a hopeful tool in treating cancer, by selectively concentrating boron compounds in tumour cells and then subjecting the tumour cells to epithermal neutron beam radiation. Benefits of BNCT: Biophysical Precision  Effective in treating recurrent, multiple, and untreated cancers  Targets cancer at cellular level  Selectively destroys cancer cells  Eliminates the need for respiratory gating and internal markers Efficient Treatment  One to two treatment sessions  Treats primary and undetected local microscopic cancer cells in parallel  Potential for more patient throughput than other radiation therapies Better Patient Experience  Does not require high-level patient positioning, improving patient comfort and reducing staff workload  Potential to greatly reduce side effects and improve patient quality of life

The global Boron Neutron Capture Therapy (BNCT) for Cancer Treatment market size is projected to grow from US$ 249 million in 2024 to US$ 3223 million in 2030; it is expected to grow at a CAGR of 53.2% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Boron Neutron Capture Therapy (BNCT) for Cancer Treatment Industry Forecast” looks at past sales and reviews total world Boron Neutron Capture Therapy (BNCT) for Cancer Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Boron Neutron Capture Therapy (BNCT) for Cancer Treatment sales for 2023 through 2029. With Boron Neutron Capture Therapy (BNCT) for Cancer Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Boron Neutron Capture Therapy (BNCT) for Cancer Treatment industry.

This Insight Report provides a comprehensive analysis of the global Boron Neutron Capture Therapy (BNCT) for Cancer Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Boron Neutron Capture Therapy (BNCT) for Cancer Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Boron Neutron Capture Therapy (BNCT) for Cancer Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Boron Neutron Capture Therapy (BNCT) for Cancer Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Boron Neutron Capture Therapy (BNCT) for Cancer Treatment.

The major global manufacturers of Boron Neutron Capture Therapy (BNCT) include Neutron Therapeutics, Sumitomo Heavy Industries, International Particle Therapy Inc (IPT), RaySearch, Neuboron Medtech, TAE Life Sciences, Stella Pharma, etc. The world"s top five vendors accounted for approximately 58% of the revenue.

Asia-Pacific is the largest market, has a share about 61%, followed by North America, and Europe, with share24% and 13%, separately.

In terms of product type, Equipment is the largest segment, occupied for a share of 60%, and in terms of application, Head and Neck Cancer has a share about 55 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Boron Neutron Capture Therapy (BNCT) for Cancer Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:
Equipment
Solution
Drug

Segmentation by Application:
Head and Neck Cancer
Brain Tumor
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Equipment
Solution
Drug

Segmentation by Application:
Head and Neck Cancer
Brain Tumor
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Neutron Therapeutics
Sumitomo Heavy Industries
International Particle Therapy Inc (IPT)
RaySearch
Neuboron Medtech
TAE Life Sciences
Stella Pharma

Please note: The report will take approximately 2 business days to prepare and deliver.